A. D. Colevas
- Oncology top 10%
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 4
- PARP inhibition in cancer therapy 3
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies 3
-
- Cancer Genomics and Diagnostics 4
-
- Chronic Lymphocytic Leukemia Research 4
-
- Advanced Breast Cancer Therapies 3
-
- Cell Adhesion Molecules Research 3
A. D. Colevas
24 papers receiving 643 citations
Peers
Comparison fields: 5 of 73
- Oncology 391
- Otorhinolaryngology 27
- Molecular Biology 355
- Cell Biology 64
- Cancer Research 55
Countries citing papers authored by A. D. Colevas
This map shows the geographic impact of A. D. Colevas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. D. Colevas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. D. Colevas more than expected).
Fields of papers citing papers by A. D. Colevas
This network shows the impact of papers produced by A. D. Colevas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. D. Colevas. The network helps show where A. D. Colevas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. D. Colevas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 84 | |
| 2 | 2012 | 46 | |
| 3 | 2010 | 8 | |
| 4 | 2010 | 2 | |
| 5 | 2010 | 1 | |
| 6 | 2009 | 26 | |
| 7 | 2007 | 7 | |
| 8 | 2007 | 7 | |
| 9 | 2007 | 4 | |
| 10 | 2007 | 11 | |
| 11 | 2006 | 16 | |
| 12 | 2006 | 2 | |
| 13 | 2006 | 4 | |
| 14 | 2006 | 7 | |
| 15 | 2005 | 5 | |
| 16 | 2005 | 4 | |
| 17 | 2005 | 61 | |
| 18 | 2004 | 5 | |
| 19 | 2004 | 16 | |
| 20 | 2004 | 85 |
About A. D. Colevas
A. D. Colevas is a scholar working on Otorhinolaryngology, Oncology and Immunology and Allergy, having authored 24 papers that have together received 652 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Genomics and Diagnostics (4 papers), Advanced Breast Cancer Therapies (3 papers), Head and Neck Cancer Studies (3 papers), Cell Adhesion Molecules Research (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (391 citations), Otorhinolaryngology (27 citations) and Molecular Biology (355 citations). A. D. Colevas has collaborated with scholars based in United States. Frequent co-authors include Ann Setser, Carolyn Cao, David H. Johnson, Dakai Xiao, Alan Sandler, Jeffrey M. Albert, Mace L. Rothenberg, Ling Geng, Jennifer A. Low and Kwang Woon Kim. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Gynecologic Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.